Clinical Trial Update: Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GVAX with cyclophosphamide and pembrolizumab in advanced metastatic colorectal cancer has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• GVAX
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-10-08